Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis

Jay S. Skyler(University of Miami), George L. Bakris(University of Chicago), Ezio Bonifacio(Technische Universität Dresden), Tamara Darsow(American Diabetes Association), Robert H. Eckel(University of Colorado Anschutz Medical Campus), Leif Groop(Lund University), Per‐Henrik Groop(University of Helsinki), Yehuda Handelsman(Tarzana Treatment Centers), Richard A. Insel(Breakthrough T1D), Chantal Mathieu(KU Leuven), Allison T. McElvaine(American Diabetes Association), Jerry P. Palmer(University of Washington), Alberto Pugliese(University of Miami), Desmond Schatz(University of Florida), Jay M. Sosenko(University of Miami), John Wilding(University of Liverpool), Robert E. Ratner(American Diabetes Association)
Diabetes
December 15, 2016
Cited by 823Open Access
Full Text

Abstract

The American Diabetes Association, JDRF, the European Association for the Study of Diabetes, and the American Association of Clinical Endocrinologists convened a research symposium, "The Differentiation of Diabetes by Pathophysiology, Natural History and Prognosis" on 10-12 October 2015. International experts in genetics, immunology, metabolism, endocrinology, and systems biology discussed genetic and environmental determinants of type 1 and type 2 diabetes risk and progression, as well as complications. The participants debated how to determine appropriate therapeutic approaches based on disease pathophysiology and stage and defined remaining research gaps hindering a personalized medical approach for diabetes to drive the field to address these gaps. The authors recommend a structure for data stratification to define the phenotypes and genotypes of subtypes of diabetes that will facilitate individualized treatment.


Related Papers

No related papers found

Powered by citation graph analysis